Sign in

CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
204580525
Phone
646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 8-K Event Executive or director change
  3. RW Other RW
  4. EFFECT Other Notice of Effectiveness
  5. 424B3 Offering Prospectus
  6. S-4/A Deal Registration Statement - Business Combination
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-4/A Deal Registration Statement - Business Combination
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. S-4/A Deal Registration Statement - Business Combination
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. UPLOAD Other SEC-generated Letter
  15. 8-K Event Other events
  16. 425 Deal Prospectus/Communication re Business Combination
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. SC 13D/A Stake Beneficial Ownership Report

Page 24 of 41 · 811 filings